Profile for Denmark Patent: 2317997
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Denmark Patent: 2317997
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | May 15, 2029 | Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate |
| ⤷ Start Trial | Jun 14, 2029 | Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate |
| ⤷ Start Trial | Jun 9, 2028 | Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate |
| ⤷ Start Trial | Jun 9, 2028 | Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate |
| ⤷ Start Trial | Jun 9, 2028 | Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate |
| ⤷ Start Trial | Jun 9, 2028 | Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
